Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy

Hypogonadotrophic Hypogonadism Clinical Trial

Official title:
Phase 4 Study That Evaluates the Presence of Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Subjects With Hypogonadotrophic Hypogonadism and Effects of Two Different Testosterone Replacement Regiments on These Parameters.

Status Completed

Clinical Trial Summary

The study searched for answers to two questions

1. Is there endothelial dysfunction, inflammation and insulin resistance in patients with congenital hypogonadotropic hypogonadism?

2. What is the effect of testosterone replacement therapy on endothelial dysfunction, inflammation and insulin resistance?

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02171390
Study type	Interventional
Source	Gulhane School of Medicine
Contact
Status	Completed
Phase	Phase 4
Start date	August 2008

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02871986` - Pubertal Induction in Individuals With Hypogonadism	N/A
Completed	`NCT01533129` - The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism	Phase 4
Completed	`NCT00138710` - Short-term Effects of Aromatase Inhibition in Obese Men	Phase 3